201 related articles for article (PubMed ID: 18940237)
21. Chemical enhancement of torsinA function in cell and animal models of torsion dystonia.
Cao S; Hewett JW; Yokoi F; Lu J; Buckley AC; Burdette AJ; Chen P; Nery FC; Li Y; Breakefield XO; Caldwell GA; Caldwell KA
Dis Model Mech; 2010; 3(5-6):386-96. PubMed ID: 20223934
[TBL] [Abstract][Full Text] [Related]
22. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y
Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683
[TBL] [Abstract][Full Text] [Related]
23. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.
Torres GE; Sweeney AL; Beaulieu JM; Shashidharan P; Caron MG
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15650-5. PubMed ID: 15505207
[TBL] [Abstract][Full Text] [Related]
24. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein.
Goodchild RE; Dauer WT
J Cell Biol; 2005 Mar; 168(6):855-62. PubMed ID: 15767459
[TBL] [Abstract][Full Text] [Related]
25. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.
Martella G; Tassone A; Sciamanna G; Platania P; Cuomo D; Viscomi MT; Bonsi P; Cacci E; Biagioni S; Usiello A; Bernardi G; Sharma N; Standaert DG; Pisani A
Brain; 2009 Sep; 132(Pt 9):2336-49. PubMed ID: 19641103
[TBL] [Abstract][Full Text] [Related]
26. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.
Hewett JW; Tannous B; Niland BP; Nery FC; Zeng J; Li Y; Breakefield XO
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7271-6. PubMed ID: 17428918
[TBL] [Abstract][Full Text] [Related]
27. Relative tissue expression of homologous torsinB correlates with the neuronal specific importance of DYT1 dystonia-associated torsinA.
Jungwirth M; Dear ML; Brown P; Holbrook K; Goodchild R
Hum Mol Genet; 2010 Mar; 19(5):888-900. PubMed ID: 20015956
[TBL] [Abstract][Full Text] [Related]
28. The nuclear envelope localization of DYT1 dystonia torsinA-ΔE requires the SUN1 LINC complex component.
Jungwirth MT; Kumar D; Jeong DY; Goodchild RE
BMC Cell Biol; 2011 May; 12():24. PubMed ID: 21627841
[TBL] [Abstract][Full Text] [Related]
29. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.
Bragg DC; Camp SM; Kaufman CA; Wilbur JD; Boston H; Schuback DE; Hanson PI; Sena-Esteves M; Breakefield XO
Neuroscience; 2004; 125(3):651-61. PubMed ID: 15099679
[TBL] [Abstract][Full Text] [Related]
30. Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice.
Uluğ AM; Vo A; Argyelan M; Tanabe L; Schiffer WK; Dewey S; Dauer WT; Eidelberg D
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6638-43. PubMed ID: 21464304
[TBL] [Abstract][Full Text] [Related]
31. TorsinA and DYT1 dystonia: a synaptopathy?
Warner TT; Granata A; Schiavo G
Biochem Soc Trans; 2010 Apr; 38(2):452-6. PubMed ID: 20298201
[TBL] [Abstract][Full Text] [Related]
32. Molecular defects of the dystonia-causing torsinA mutation.
Pham P; Frei KP; Woo W; Truong DD
Neuroreport; 2006 Nov; 17(16):1725-8. PubMed ID: 17047461
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.
Hettich J; Ryan SD; de Souza ON; Saraiva Macedo Timmers LF; Tsai S; Atai NA; da Hora CC; Zhang X; Kothary R; Snapp E; Ericsson M; Grundmann K; Breakefield XO; Nery FC
Hum Mutat; 2014 Sep; 35(9):1101-13. PubMed ID: 24930953
[TBL] [Abstract][Full Text] [Related]
34. TorsinA Is Functionally Associated with Spermatogenesis.
Serrano JB; Martins F; Pereira CD; van Pelt AMM; da Cruz E Silva OAB; Rebelo S
Microsc Microanal; 2019 Feb; 25(1):221-228. PubMed ID: 30246678
[TBL] [Abstract][Full Text] [Related]
35. Membrane defects and genetic redundancy: Are we at a turning point for DYT1 dystonia?
Cascalho A; Jacquemyn J; Goodchild RE
Mov Disord; 2017 Mar; 32(3):371-381. PubMed ID: 27911022
[TBL] [Abstract][Full Text] [Related]
36. Behavioral and electrophysiological characterization of Dyt1 heterozygous knockout mice.
Yokoi F; Chen HX; Dang MT; Cheetham CC; Campbell SL; Roper SN; Sweatt JD; Li Y
PLoS One; 2015; 10(3):e0120916. PubMed ID: 25799505
[TBL] [Abstract][Full Text] [Related]
37. A novel conditional knock-in approach defines molecular and circuit effects of the DYT1 dystonia mutation.
Weisheit CE; Dauer WT
Hum Mol Genet; 2015 Nov; 24(22):6459-72. PubMed ID: 26370418
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the porcine TOR1A gene: The first step towards generation of a pig model for dystonia.
Henriksen C; Madsen LB; Bendixen C; Larsen K
Gene; 2009 Feb; 430(1-2):105-15. PubMed ID: 19028553
[TBL] [Abstract][Full Text] [Related]
39. 4-Phenylbutyrate attenuates the ER stress response and cyclic AMP accumulation in DYT1 dystonia cell models.
Cho JA; Zhang X; Miller GM; Lencer WI; Nery FC
PLoS One; 2014; 9(11):e110086. PubMed ID: 25379658
[TBL] [Abstract][Full Text] [Related]
40. TorsinA participates in endoplasmic reticulum-associated degradation.
Nery FC; Armata IA; Farley JE; Cho JA; Yaqub U; Chen P; da Hora CC; Wang Q; Tagaya M; Klein C; Tannous B; Caldwell KA; Caldwell GA; Lencer WI; Ye Y; Breakefield XO
Nat Commun; 2011 Jul; 2():393. PubMed ID: 21750546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
